ThermoScientific to distribute IMAT-supported Iuvo™ technology in their Cellomics high-content analysis platform

The Iuvo™ platform line (available from Bellbrook Labs) are microchannel cell-based assays developed by Dr. David Beebe (with two phases of IMAT support) at the Wisconsin Institute for Medical Research. In early February 2012, Bellbrook Labs and Thermo Fisher Scientific, Inc announced an agreement under which Thermo Fisher will be distributing two of the Iuvo™ products for use with their Cellomics instruments. This agreement will result in broader access to the technology by the research community, and is a testament to the transformative potential of this unique innovation. Congratulations to Dr. Beebe and everyone on the Iuvo™ development team!